Editorial to the Postmarketing Surveillance on the Clinical Use of Edoxaban in Patients With Nonvalvular Atrial Fibrillation (ETNA-AF Japan): One-Year Safety and Effectiveness Analyses
Journal of Arrhythmia - Netherlands
doi 10.1002/joa3.12340
Full Text
Open PDFAbstract
Available in full text
Date
April 15, 2020
Authors
Publisher
Wiley